Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZIMMER BIOMET HOLDINGS, INC.

(ZBH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/14/2021 10/15/2021 10/18/2021 10/19/2021 10/20/2021 Date
145.63(c) 146.36(c) 144.97(c) 148.92(c) 150.13 Last
797 281 883 308 1 026 514 1 019 167 1 086 499 Volume
+2.00% +0.50% -0.95% +2.72% +0.81% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 8 066 M - -
Net income 2021 967 M - -
Net Debt 2021 6 468 M - -
P/E ratio 2021 33,2x
Yield 2021 0,64%
Sales 2022 8 476 M - -
Net income 2022 1 285 M - -
Net Debt 2022 5 006 M - -
P/E ratio 2022 25,3x
Yield 2022 0,67%
Capitalization 31 353 M 31 353 M -
EV / Sales 2021 4,69x
EV / Sales 2022 4,29x
Nbr of Employees 20 000
Free-Float 66,7%
More Financials
Company
Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones,... 
More about the company
Ratings of Zimmer Biomet Holdings, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about ZIMMER BIOMET HOLDINGS, INC.
10/07ZIMMER BIOMET : Announces Webcast and Conference Call of Third Quarter 2021 Financial Resu..
PR
10/05ZIMMER BIOMET : Barclays Cuts Price Target on Zimmer Biomet to $186 From $210, Keeps Overw..
MT
09/29ZIMMER BIOMET HOLDINGS, INC. : Ex-dividend day for
FA
09/28WALL STREET STOCK EXCHANGE : Is inflation still transitionary?
09/28ANALYST RECOMMENDATIONS : 888, Chesapeake Energy, Conocophillips, Marathon Oil, Playtech....
09/27ZIMMER BIOMET : Needham Lowers PT for Zimmer Biomet Holdings to $187 From $202 Given Impac..
MT
09/15ZIMMER BIOMET : Announces Key Additions to 'NewCo' Leadership Team, Transaction to Form Ne..
AQ
09/14ZIMMER BIOMET : Names Finance Chief for Company Spin-Off
MT
09/14ZIMMER BIOMET : Announces Key Additions to "NewCo" Leadership Team; Transaction to Form Ne..
PR
09/14Zimmer Biomet Holdings, Inc. Announces Executive Changes
CI
09/14Zimmer Biomet Holdings, Inc. Appoints Richard J. Heppenstall as Chief Financial Officer
CI
09/03ZIMMER BIOMET : Maintains Q3 Cash Dividend at $0.24 a Share, Payable Oct. 29 to Shareholde..
MT
09/03ZIMMER BIOMET : To Pay Q3 Dividend
MT
09/03ZIMMER BIOMET : Announces Quarterly Dividend for Third Quarter of 2021
PR
09/03Zimmer Biomet Holdings, Inc. Announces Quarterly Dividend for Third Quarter of 2021, Pa..
CI
More news
News in other languages on ZIMMER BIOMET HOLDINGS, INC.
09/03Zimmer Biomet Holdings, Inc. annonce le versement d'un dividende trimestriel pour le tr..
08/05IRW-PRESS : Altius Renewable Royalties Corp. : Altius Renewable Royalties gibt erfolgreich..
2020Medicrea n’échappe pas au destin américain des medtech françaises
2020MEDARTIS : nouvelle responsable pour la région Emea
2020Medartis ernennt Mareike Loch zur Vice President EMEA
More news
Analyst Recommendations on ZIMMER BIOMET HOLDINGS, INC.
More recommendations
Chart ZIMMER BIOMET HOLDINGS, INC.
Duration : Period :
Zimmer Biomet Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZIMMER BIOMET HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 31
Last Close Price 150,13 $
Average target price 185,21 $
Spread / Average Target 23,4%
EPS Revisions
Managers and Directors
Bryan C. Hanson Chairman, President & Chief Executive Officer
Suketu P. Upadhyay Chief Financial Officer & Executive Vice President
Zeeshan Tariq Chief Information Officer & Senior Vice President
Nitin Goyal Chief Science, Technology & Innovation Officer
Ivan Tornos Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
ZIMMER BIOMET HOLDINGS, INC.-3.36%31 101
ABBOTT LABORATORIES9.00%211 568
MEDTRONIC PLC4.32%164 458
BECTON, DICKINSON AND COMPANY-2.99%69 710
HOYA CORPORATION22.25%57 064
DEXCOM, INC.48.77%53 217